Drugs & Pharmaceuticals M&A » By The Online Investor Staff, updated Tue., Dec. 6, 10:02 AM
Recent mergers and acquisitions in the Drugs & Pharmaceuticals M&A category.
| This Slide: #98 of 100 |
Slide #98. Auxilium Pharmaceuticals — Actient Holdings LLC
Acquirer:
Auxilium Pharmaceuticals (AUXL)
Acquiree:
Actient Holdings LLC
Details:
GTCR, a leading private equity firm, announced today it has sold its portfolio company, Actient Holdings LLC ("Actient"), to Auxilium Pharmaceuticals Inc. (NASDAQ:AUXL,Auxilium), a specialty biopharmaceutical company. Headquartered in Lake Forest, Illinois, Actient is a specialty pharmaceutical company focused on developing, acquiring and marketing products that significantly improve patient outcomes.
Auxilium Pharmaceuticals is a biopharmaceutical company with a focus on developing and commercializing products for specialist audiences. Co. has a range of first- and second-line products across multiple indications, including men's healthcare, orthopedics, dermatology and other therapeutic areas. Among other products in the U.S., Co. markets Testim® (testosterone gel) for the topical treatment of hypogonadism; TESTOPEL® (testosterone pellets) a long-acting implantable testosterone replacement therapy product; STENDRA™ (avanafil), an oral erectile dysfunction (ED) therapy; as well as Edex® (alprostadil for injection), an injectable treatment for ED.
Open the AUXL Page at The Online Investor »
|
|||||||||
Open the AUXL Page at The Online Investor (in a new window) »
 Free AUXL Email Alerts:
Get SEC Filing Alerts Get Dividend Alerts 
|
Avg. Broker Rec.
|
Hold (2.00 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on Zacks ABR data; powered by Xignite |
